1-4 of 4
Sarolta Nahajevszky, MD
Close
Sort by
Journal Articles

Clinical Characteristics of JAK2 V617F Mutation Positive Acute Myeloid Leukemia.

Sarolta Nahajevszky, MD, Hajnalka Andrikovics, MD, Zoltan Matrai, MD, Nora Lovas, MD, Sandor Lueff, MD, Tamas Masszi, MD
Journal: Blood
Blood (2006) 108 (11): 4508.
https://doi.org/10.1182/blood.V108.11.4508.4508
Published: 2006
Journal Articles

HFE C282Y Mutation as a Genetic Modifier Influencing Disease Susceptibility for JAK2 V617F Positive Chronic Myeloproliferative Disease.

Hajnalka Andrikovics, MD, PhD, Nora Meggyesi, Aniko Szilvasi, Julia Tamaska, MD, Gabriella Halm, MD, Sandor Lueff, MD, Sarolta Nahajevszky, MD, Miklos Egyed, MD, PhD, Judit Varkonyi, MD, PhD, Gabor Mikala, MD, PhD, Andrea Sipos, MD, Attila Tordai, MD, PhD, Tamas Masszi, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 4904.
https://doi.org/10.1182/blood.V108.11.4904.4904
Published: 2006
Journal Articles

Striking Coincidence of IgD M-Protein and Translocation t(11;14) in Hungarian Myeloma Patients.

Gabor Mikala, MD, PhD, Emma Adam, Andras Kozma, Balazs Kapas, MD, Sarolta Nahajevszky, MD, Tamas Masszi, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 5046.
https://doi.org/10.1182/blood.V108.11.5046.5046
Published: 2006
Journal Articles

Effective Treatment of Basophilic Leukemia of the Central Nervous System in a CML Patient with the Combination of Imatinib Mesylate and Valproic Acid.

Sarolta Nahajevszky, MD, Maria Magocsi, PhD, Gabor Mikala, PhD, Hajnalka Andrikovics, PhD, Emma Adam, Tamas Masszi, PhD
Journal: Blood
Blood (2005) 106 (11): 4886.
https://doi.org/10.1182/blood.V106.11.4886.4886
Published: 2005